Spheroid Engineering in Microfluidic Devices.

Area of Science:

• Biotechnology
• Cell Biology
• Biomedical Engineering

Background:

• Two-dimensional (2D) cell cultures lack the complex cell-cell and cell-extracellular matrix interactions crucial for mimicking in vivo environments.
• Three-dimensional (3D) cell cultures, particularly spheroids, offer a more physiologically relevant model by enabling nutrient/gas transport and replicating multicellular organization.
• Conventional spheroid fabrication methods are labor-intensive and yield low throughput with poor size control.

Purpose of the Study:

• To review recent advancements in microfluidic techniques for spheroid fabrication.
• To explore the organ-on-a-chip applications of microfluidically generated spheroids.
• To highlight the utility of these systems in disease modeling and drug development.

Main Methods:

• Focuses on microfluidic approaches for spheroid generation, emphasizing precision and scalability.
• Discusses the advantages of microfluidic devices for culturing spheroids, including controlled perfusion and shear stress simulation.
• Reviews organ-on-a-chip systems utilizing microfluidic spheroids.

Main Results:

• Microfluidic methods enable rapid, inexpensive, and precise fabrication of spheroids with controlled sizes.
• Microfluidic culture systems allow for dynamic mimicking of in vivo conditions, such as fluid shear effects.
• Spheroids fabricated and cultured in microfluidic devices show promise for accurate disease modeling and drug screening.

Conclusions:

• Microfluidic spheroid fabrication represents a significant improvement over conventional methods, offering higher throughput and precision.
• Microfluidic spheroid-based organ-on-a-chip platforms provide powerful tools for in vitro research.
• These advanced 3D culture systems are essential for accelerating drug development and understanding complex diseases.